Symptomzentrierte Ansicht
Brustbeschwerden
Substanzen, die Brustbeschwerden disproportional melden — sortiert nach ROR.
130 von 130 angezeigt
| Substanz ↓ | ROR [95% CI] | Meldungen | Kategorie | Fachinformation |
|---|---|---|---|---|
| 2.7 [1.6–4.6] | 14 | algemeen | neu | |
| 6.3 [4.0–9.9] | 19 | algemeen | neu | |
| 3.0 [2.3–3.9] | 55 | algemeen | neu | |
| 9.7 [7.0–13.4] | 39 | algemeen | neu | |
| 3.1 [2.9–3.3] | 818 | algemeen | neu | |
| 3.2 [3.0–3.5] | 978 | algemeen | neu | |
| 2.7 [2.2–3.4] | 90 | algemeen | neu | |
| 4.6 [4.4–4.8] | 2.626 | algemeen | neu | |
| 3.0 [2.7–3.3] | 394 | algemeen | neu | |
| 6.8 [6.1–7.6] | 345 | algemeen | neu | |
| 3.6 [2.9–4.5] | 84 | algemeen | neu | |
| 5.1 [5.0–5.3] | 3.566 | algemeen | neu | |
| 5.1 [4.8–5.5] | 763 | algemeen | neu | |
| 7.0 [6.4–7.8] | 402 | algemeen | neu | |
| 7.0 [6.4–7.8] | 402 | algemeen | neu | |
| 4.2 [3.5–5.0] | 114 | algemeen | neu | |
| 2.5 [2.2–2.9] | 209 | algemeen | neu | |
| 3.3 [1.6–6.9] | 7 | algemeen | neu | |
| 3.4 [2.3–4.8] | 30 | algemeen | neu | |
| 12.0 [9.8–14.7] | 99 | algemeen | neu | |
| 6.4 [4.7–8.7] | 43 | algemeen | neu | |
| 3.4 [3.1–3.8] | 426 | algemeen | neu | |
| 3.8 [3.5–4.0] | 817 | algemeen | neu | |
| 3.7 [2.9–4.5] | 85 | algemeen | neu | |
| 3.7 [2.9–4.5] | 85 | algemeen | neu | |
| 4.7 [4.4–4.9] | 1.545 | algemeen | neu | |
| 4.7 [4.4–4.9] | 1.545 | algemeen | neu | |
| 3.7 [2.7–4.9] | 46 | algemeen | neu | |
| 7.0 [6.7–7.3] | 2.188 | algemeen | neu | |
| 5.6 [5.2–6.0] | 699 | algemeen | neu | |
| 3.5 [2.9–4.2] | 112 | algemeen | neu | |
| 5.5 [4.6–6.6] | 127 | algemeen | neu | |
| 8.6 [5.9–12.7] | 27 | algemeen | neu | |
| 4.8 [4.0–5.8] | 108 | algemeen | neu | |
| 2.3 [1.9–2.8] | 111 | algemeen | neu | |
| 2.4 [2.0–2.8] | 140 | algemeen | neu | |
| 6.8 [5.9–7.9] | 187 | algemeen | neu | |
| 4.2 [3.6–4.9] | 160 | algemeen | neu | |
| 6.0 [4.9–7.3] | 97 | algemeen | neu | |
| 2.2 [1.7–2.8] | 61 | algemeen | neu | |
| 3.2 [2.6–3.9] | 96 | algemeen | neu | |
| 3.2 [3.0–3.4] | 1.201 | algemeen | neu | |
| 2.7 [2.6–2.9] | 1.250 | algemeen | neu | |
| 2.3 [1.7–3.3] | 33 | algemeen | neu | |
| 4.9 [4.7–5.3] | 1.096 | algemeen | neu | |
| 2.7 [2.4–3.1] | 316 | algemeen | neu | |
| 2.7 [2.4–3.1] | 316 | algemeen | neu | |
| 7.6 [7.3–7.8] | 2.853 | algemeen | neu | |
| 2.6 [2.2–3.0] | 196 | algemeen | neu | |
| 6.6 [6.3–6.8] | 3.579 | algemeen | neu | |
| 5.7 [5.5–5.8] | 4.442 | algemeen | neu | |
| 3.9 [3.4–4.3] | 283 | algemeen | neu | |
| 5.3 [5.1–5.6] | 1.449 | algemeen | neu | |
| 5.2 [5.0–5.5] | 1.600 | algemeen | neu | |
| 2.6 [2.2–3.1] | 139 | algemeen | neu | |
| 8.8 [8.4–9.2] | 1.963 | algemeen | neu | |
| 2.7 [2.1–3.5] | 56 | algemeen | neu | |
| 8.7 [2.7–27.5] | 3 | algemeen | neu | |
| 8.6 [7.8–9.6] | 343 | algemeen | neu | |
| 4.6 [4.0–5.3] | 204 | algemeen | neu | |
| 4.4 [3.5–5.6] | 73 | algemeen | neu | |
| 4.5 [3.5–5.6] | 70 | algemeen | neu | |
| 4.3 [3.6–5.1] | 134 | algemeen | neu | |
| 2.0 [1.1–3.7] | 11 | algemeen | neu | |
| 4.8 [3.4–6.6] | 37 | algemeen | neu | |
| 3.9 [3.6–4.2] | 619 | algemeen | neu | |
| 5.1 [4.5–5.8] | 224 | algemeen | neu | |
| 4.0 [3.2–5.0] | 80 | algemeen | neu | |
| 7.7 [7.3–8.1] | 1.385 | algemeen | neu | |
| 9.1 [7.8–10.7] | 161 | algemeen | neu | |
| 9.4 [8.1–11.0] | 172 | algemeen | neu | |
| 3.4 [2.5–4.5] | 46 | algemeen | neu | |
| 6.3 [5.5–7.1] | 237 | algemeen | neu | |
| 4.6 [3.7–5.8] | 75 | algemeen | neu | |
| 4.0 [3.5–4.6] | 214 | algemeen | neu | |
| 7.0 [6.4–7.6] | 543 | algemeen | neu | |
| 3.9 [2.8–5.3] | 39 | longevity | neu | |
| 4.6 [3.8–5.6] | 100 | algemeen | neu | |
| 3.7 [3.5–3.9] | 1.059 | algemeen | neu | |
| 3.6 [3.4–3.9] | 1.074 | algemeen | neu | |
| 7.4 [6.2–8.8] | 124 | algemeen | neu | |
| 4.4 [3.6–5.4] | 101 | algemeen | neu | |
| 6.7 [6.4–6.9] | 3.487 | algemeen | neu | |
| 6.4 [6.2–6.6] | 3.692 | algemeen | neu | |
| 6.7 [6.4–7.0] | 1.843 | algemeen | neu | |
| 5.6 [5.4–5.8] | 2.601 | algemeen | neu | |
| 4.2 [4.1–4.4] | 3.731 | algemeen | neu | |
| 3.3 [3.1–3.6] | 619 | algemeen | neu | |
| 7.1 [6.7–7.6] | 1.174 | algemeen | neu | |
| 5.1 [4.9–5.3] | 2.017 | algemeen | neu | |
| 20.4 [17.4–23.9] | 171 | algemeen | neu | |
| 8.5 [7.1–10.2] | 120 | algemeen | neu | |
| 7.5 [6.4–8.8] | 161 | algemeen | neu | |
| 8.6 [7.0–10.6] | 95 | algemeen | neu | |
| 3.8 [3.2–4.4] | 155 | algemeen | neu | |
| 2.5 [2.2–3.0] | 149 | algemeen | neu | |
| 3.6 [3.0–4.3] | 120 | algemeen | neu | |
| 3.2 [2.9–3.6] | 299 | algemeen | neu | |
| 14.1 [13.1–15.3] | 668 | algemeen | neu | |
| 37.7 [16.8–84.5] | 7 | algemeen | neu | |
| 3.7 [3.2–4.4] | 164 | algemeen | neu | |
| 20.5 [19.3–21.7] | 1.199 | algemeen | neu | |
| 2.8 [1.8–4.3] | 20 | algemeen | neu | |
| 3.6 [3.1–4.2] | 162 | algemeen | neu | |
| 6.9 [6.6–7.1] | 3.019 | algemeen | neu | |
| 6.0 [5.8–6.1] | 4.371 | algemeen | neu | |
| 4.3 [3.9–4.8] | 385 | algemeen | neu | |
| 2.1 [1.5–3.0] | 31 | algemeen | neu | |
| 5.0 [3.9–6.4] | 65 | algemeen | neu | |
| 3.3 [2.8–3.9] | 156 | algemeen | neu | |
| 4.1 [3.4–4.8] | 137 | algemeen | neu | |
| 3.9 [3.6–4.2] | 749 | algemeen | neu | |
| 3.7 [3.5–3.9] | 1.022 | algemeen | neu | |
| 4.8 [3.9–5.9] | 92 | algemeen | neu | |
| 3.5 [3.0–4.1] | 172 | algemeen | neu | |
| 2.0 [1.1–3.8] | 10 | algemeen | neu | |
| 3.5 [2.6–4.6] | 48 | algemeen | neu | |
| 4.6 [3.4–6.2] | 42 | algemeen | neu | |
| 2.6 [2.5–2.8] | 1.544 | algemeen | neu | |
| 6.1 [5.6–6.7] | 552 | algemeen | neu | |
| 5.7 [5.6–5.8] | 7.379 | algemeen | neu | |
| 5.7 [5.6–5.8] | 7.412 | algemeen | neu | |
| 3.7 [3.1–4.3] | 157 | algemeen | neu | |
| 7.2 [6.3–8.3] | 217 | algemeen | neu | |
| 9.3 [8.1–10.7] | 208 | algemeen | neu | |
| 8.1 [3.8–17.2] | 7 | algemeen | neu | |
| 7.2 [3.4–15.2] | 7 | algemeen | neu | |
| 4.5 [1.7–12.2] | 4 | algemeen | neu | |
| 4.9 [4.7–5.3] | 1.096 | algemeen | neu | |
| 4.2 [3.3–5.2] | 76 | algemeen | neu |
ROR = Reporting Odds Ratio gegenüber dem gesamten FAERS-Korpus. Ein Signal ist keine Ursache. Quelle: openFDA (FAERS).